Stocks
Dicerna Pharmaceuticals (DRNA) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 0.78 | 1.92 | -3.34 | -9.92 | -10.2 | -9.00 | ||
| Changes by years, y/y, % | -133% | +145% | -274% | +197% | +3% | +34.0% | |||
Dicerna Pharmaceuticals. EV/EBITDA
Dicerna Pharmaceuticals. EV/EBITDA, changes, %
Dicerna Pharmaceuticals (DRNA) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2020Q3 | FY2020Q4 | FY2021Q1 | FY2021Q2 | FY2021Q3 | LTM ? | |||
| EV/EBITDA | ? | -6.61 | -10.2 | -12.4 | -18.8 | -9.00 | -9.00 | |
| Changes by years, y/y, % | -3% | +2% | +117% | +87% | +36% | |||
| Changes by quarters, q/q, % | -34% | +54% | +22% | +52% | -52% | |||
